UK markets closed

Targeted Medical Pharma, Inc. (TRGM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 10:47AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 322.99k
Enterprise value 5.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.03
Price/book (mrq)N/A
Enterprise value/revenue 1.05
Enterprise value/EBITDA -3.33

Trading information

Stock price history

Beta (5Y monthly) -0.35
52-week change 30.00%
S&P500 52-week change 322.38%
52-week high 30.0001
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 530.19M
Implied shares outstanding 63.23B
Float 811.58M
% held by insiders 161.65%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2015
Most-recent quarter (mrq)31 Dec 2015

Profitability

Profit margin -57.86%
Operating margin (ttm)-28.48%

Management effectiveness

Return on assets (ttm)-47.96%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.26M
Revenue per share (ttm)0.19
Quarterly revenue growth (yoy)-9.00%
Gross profit (ttm)N/A
EBITDA -1.66M
Net income avi to common (ttm)-3.04M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.64k
Total cash per share (mrq)0
Total debt (mrq)5.29M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.06
Book value per share (mrq)-0.47

Cash flow statement

Operating cash flow (ttm)-1.28M
Levered free cash flow (ttm)-174.02k